2 news items
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
SLNO
2 May 24
. Soleno intends to use the net proceeds from this offering to fund its current research and development efforts primarily focused on advancing
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
SLNO
2 May 24
book-running managers for the public offering. Soleno intends to use the net proceeds from this offering to fund its current research
- Prev
- 1
- Next